Market Place
Sourcing Support
All News #Library
Others
HTL Biotechnology wins the Responsible Care 2025 Award
19 Sep 2025 //
PRESS RELEASE
BIOPHTA 6.5 million Euros Seed Funding
03 Jun 2024 //
PRESS RELEASE
HTL launches new CSR strategy
09 Oct 2023 //
PRESS RELEASE
HTL team in Korea and China to meet their clients and expend business
14 Mar 2023 //
PRESS RELEASE
HTL, winner of the special jury prize at the CCI France International Trophy
28 Jun 2022 //
PRESS RELEASE
François Fournier as new CEO
08 Jun 2022 //
PRESS RELEASE
HTL Announces Its Incubator`s Equity Investment In GelMEDIX
10 Mar 2022 //
PRESS RELEASE
HTL announces Montagu as new investor alongside its historical shareholders, Naxicap and Téthys Invest
28 Feb 2022 //
PRESS RELEASE
HTL launches a new, cutting-edge bioproduction unit for pharmaceu
30 Sep 2021 //
PRESS RELEASE
Eirion Therapeutics Announces Strategic Agreement for HTL Biotech
08 Sep 2021 //
PRESS RELEASE
Terasaki Institute for Biomedical Innovation and HTL Biotechnology
07 May 2021 //
PR NEWSWIRE
HTL Biotechnology, Echelon Biosciences Announce Strategic Partnership
16 Apr 2021 //
PRESS RELEASE
LabCom GELMECS, a new shared laboratory for biomaterials in regenerative medicine
10 Dec 2020 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.